相关实验视频
Updated: Sep 17, 2025

10:40
Author Spotlight: Insight Into Advances in Prion Diseases Research
Published on: August 11, 2023
580
对目前的理论和潜在的治疗方法进行审查,以治疗性疾病
Saranya Udayakumar1, Agnishwar Girigoswami1, Koyeli Girigoswami2
1Faculty of Allied Health Sciences, Chettinad Hospital and Research Institute, Chettinad Academy of Research and Education, Chettinad Health City, Kelambakkam, Tamilnadu, 603103, India.
Molecular biology reports
|July 4, 2025
概括
子疾病涉及错误折叠的蛋白质 (PrPC),导致致命的神经退行. 本综述探讨了抗体治疗和RNA干扰等新型疗法,以对抗这些具有挑战性的疾病.
科学领域:
- 神经科学是一个神经科学.
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 性疾病是致命的神经退行性疾病,影响人类和动物.
- 通过错误折叠的细胞蛋白 (PrPC) 形成致病性异型 (PrPSc) 的特征.
- 包括克鲁茨菲尔特-雅各布病和致命的家族失眠等疾病,预后不好.
研究的目的:
- 审查对性疾病的新型治疗策略.
- 探索针对PrPC转化为PrPSc的治疗方法.
- 讨论新兴疗法在管理子疾病方面的潜力.
主要方法:
- 关于病治疗的当前文献的综述.
- 专注于基于抗体的治疗方法.
- 探索RNA干扰,反意义寡核酸,抗聚合化合物,β片断裂剂和干细胞疗法.
主要成果:
- 基于抗体的治疗旨在防止蛋白错误折叠.
- RNA干扰和反意义寡核酸提供了基因沉默方法.
- 抗聚合化合物,β叶断裂剂和干细胞疗法提供了替代治疗途径.
结论:
- 新的治疗方法对子疾病有希望.
- 准质蛋白转化和聚合是一个关键的战略.
- 对这些不同疗法的进一步研究对于有效的治疗开发至关重要.
相关概念视频
Amyloid Fibrils
9.9K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.9K
Parkinson's Disease: Overview
716
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
716
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
999
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
999

